Citadel Advisors
SKIN icon

Citadel Advisors’s SkinHealth Systems SKIN Stock Holding History

Citadel Advisors’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,025
Closed -$18.2K – 14746
2026
Q1 		$18.2K Sell
1,025
-500
-33% -$12.3K ﹤0.01% 12688
2025
Q4 		$42.4K Buy
1,525
+240
+19% +$6.94K ﹤0.01% 12111
2025
Q3 		$51.1K Buy
1,285
+620
+93% +$25.2K ﹤0.01% 12193
2025
Q2 		$25.4K Sell
665
-555
-45% -$15.6K ﹤0.01% 12046
2025
Q1 		$32.7K Sell
1,220
-790
-39% -$24.1K ﹤0.01% 12736
2024
Q4 		$63.9K Sell
2,010
-9,700
-83% -$305K ﹤0.01% 12108
2024
Q3 		$337K Sell
11,710
-365
-3% -$12K ﹤0.01% 9078
2024
Q2 		$464K Buy
12,075
+4,260
+55% +$240K ﹤0.01% 8201
2024
Q1 		$694K Sell
7,815
-2,490
-24% -$162K ﹤0.01% 7682
2023
Q4 		$641K Buy
10,305
+4,065
+65% +$305K ﹤0.01% 7577
2023
Q3 		$751K Buy
6,240
+3,470
+125% +$487K ﹤0.01% 7187
2023
Q2 		$464K Sell
2,770
-3,630
-57% -$754K ﹤0.01% 8114
2023
Q1 		$1.62M Sell
6,400
-2,610
-29% -$604K ﹤0.01% 5768
2022
Q4 		$1.64M Buy
9,010
+2,665
+42% +$575K ﹤0.01% 5854
2022
Q3 		$1.5M Sell
6,345
-520
-8% -$131K ﹤0.01% 6165
2022
Q2 		$1.77M Buy
6,865
+3,955
+136% +$1.06M ﹤0.01% 5805
2022
Q1 		$982K Sell
2,910
-5,945
-67% -$1.96M ﹤0.01% 7729
2021
Q4 		$4.28M Sell
8,855
-8,410
-49% -$4.33M ﹤0.01% 4614
2021
Q3 		$8.97M Buy
17,265
+9,945
+136% +$4.37M ﹤0.01% 3259
2021
Q2 		$2.46M Buy
7,320
+6,025
+465% +$1.65M ﹤0.01% 6090
2021
Q1 		$280K Buy
+1,295
New +$285K ﹤0.01% 11017

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors's SKIN Position: Q2 2026 in Review

Citadel Advisors increased its SkinHealth Systems (SKIN) stake by 296% in Q2 2026, buying an estimated $97.3K and bringing the position to 8,515 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #12551.

Citadel Advisors first reported a position in SKIN in Q1 2021 and has held it in 20 quarters since. The position peaked at $53M in Q2 2021. 93 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Citadel Advisors held 8,515 shares of SkinHealth Systems worth $118K as of Q2 2026.
  • Citadel Advisors bought 6,366 SkinHealth Systems shares in Q2 2026, an estimated $97.3K.
  • SkinHealth Systems made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12551 holding.
  • Citadel Advisors first reported a position in SkinHealth Systems in Q1 2021 and has held it in 20 quarters since.
  • Citadel Advisors's SkinHealth Systems position peaked at $53M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.